RainDance Technologies Launches Comprehensive Sequencing Panel for Cancer Mutation Screening and Research
Published: Apr 02, 2012
LEXINGTON, Mass. & CHICAGO--(BUSINESS WIRE)--RainDance Technologies, Inc., the Digital Biology™ company, today announced the worldwide availability of its new panel for cancer mutation screening research using any next-generation sequencing (NGS) system. The RainDance Cancer Hotspot Panel enables researchers to simultaneously interrogate more than 13,000 cancer “hotspots” across 54 genes.